US Patent 10189846 Hepatitis B antiviral agents
Patent 10189846 was granted and assigned to Enanta Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2017
Date of Patent
January 29, 2019
Patent Applicant
Patent Application Number
15617445
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10189846 Hepatitis B antiviral agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
